Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 4, 1997, Pages 437-447

  Carson, Richard E ^a   Breier, Alan ^b   De Bartolomeis, Andrea ^b   Saunders, Richard C ^b   Su, Tom P ^b   Schmall, Bernard ^a   Der, Margaret G ^a   Pickar, David ^b   Eckelman, William C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amphetamine; Infusion; Modeling; Raclopride

Indexed keywords

AMPHETAMINE; BENZAMIDE; CARBON 11; IODINE 123; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CEREBELLUM; CONTROLLED STUDY; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; NEUROTRANSMITTER RELEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; RHESUS MONKEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030888681     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199704000-00009     Document Type: Article

References (35)

1. Abi-Dargham A, Laruelle M, Seibyl J, et al. (1994) SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35:228-238
2. Breier A, Su TP, Elman I, et al. (1996) Schizophrenia is associated with elevated amphetamine-induced dopamine release. Soc Neurosci Abstr 22:266
3. 18F]-cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 13:24-42
4. Carson RE, Yan Y, Daube-Witherspoon ME, et al. (1993b) An approximation formula for the variance of PET region-of-interest values. IEEE Trans Med Imag 12:240-250
5. 11C-raclopride and continuous infusion. J Cereb Blood Flow Metab 15:5123
6. de Bartolomeis A, Der MG, Jagoda E, et al. (1996) Development and validation of a high-performance liquid chromatographic method for the determination of raclopride in plasma J Labelled Compd Radiopharm 37:697-699
7. 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780
8. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350-356
9. Dewey SL, Smith GS, Logan J, et al. (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in-vivo microdialysis. J Neurosci 15:821-829
10. 2 receptor ligands. J Labelled Compd Radiopharm 24:931-940
11. Endres CJ, Carson RE, Kolachana B, et al. (1996) Simultaneous modeling of [C-11]raclopride PET and dopamine microdialysis data. J Nucl Med 37:77P
12. 2 dopamine receptor binding in the living human brain by PET. Science 231:258-261
13. 2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696-708
14. Farde L, Nordström A-L, Wiesel FA, et al. (1992) Positron emission tomography analysis of central D1 and D2 dopamine receptor occupancy in patients being treated with classic neuroleptic and clozapine. Arch Gen Psychiatry 49:538-544
15. Huang S-C, Phelps ME, Hoffman EJ, Kuhl DE (1981) Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose. J Cereb Blood Flow Metab 1:391-401
16. Huang SC, Barrior JR, Yu DC, et al. (1991) Modelling approach for separating blood time-activity curves in positron emission tomographic studies. Phys Med Biol 36:749-761
17. Hume SP, Myers R, Bloomfield PM, et al. (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47-54
18. Ichise M, Ballinger JR, Golan H, et al. (1996) Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med 37:513-520
19. 2 receptor in nonhuman primates. Synapse 10:177-184
20. Kapur S, Remington G, Zipursky RB, Wilson AA, Houle S (1995) The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci 57:103-107
21. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735-744
22. 11C]raclopride studies. J Cereb Blood Flow Metab 16:42-52
23. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J Cereb Blood Flow Metab 14:453-465
24. Laruelle M, Abi-Dargham A, van Dyck CH, et al. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36:1182-1190
25. Litton JE, Holte S, Eriksson L (1990) Evaluation of the Karolinska new positron camera system: the Scanditronix PC2048-15B. IEEE Trans Nucl Sci 37:743-748
26. 11C-methyl]-(-)-cocaine: PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747
27. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010
28. Minoshima S, Koeppe RA, Mukhopadhyay S, et al. (1994) Equilibrium measurement of [C-11]raclopride distribution volume in the brain using a continuous infusion technique. J Nucl Med 35:140P
29. Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH (1993) In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse 13:212-222
30. Nordstrom AL, Farde L, Halldin C (1992) Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106:433-438
31. 2 dopamine receptor occupancy in the living human brain. Psychopharmacology 110:265-272
32. 14C-iodoantipyrine. Am J Physiol 258:H1585-H1598
33. Seibyl JP, Zea-Ponce Y, Brenner L, et al. (1996) Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796. J Nucl Med 37:11-16
34. 2 dopamine receptors. Synapse 12:236-241
35. 3H]raclopride binding in the rat brain. Synapse 9:188-194